The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - NIH and Philips have a Cooperative Research and Development Agreement. NIH has intellectual property in the field, including among other patents and patent applications, Patent: “System, methods, and instrumentation for image guided prostate treatment” US

Does size matter? Lesion size as an indicator of number of cores needed to detect clinically significant prostate cancer.
 
Amir H. Lebastchi
No Relationships to Disclose
 
Luke P. O'Connor
No Relationships to Disclose
 
Alex Z. Wang
No Relationships to Disclose
 
Nitin Yerram
No Relationships to Disclose
 
Sandeep Gurram
No Relationships to Disclose
 
Graham Hale
No Relationships to Disclose
 
Jonathon B. Bloom
No Relationships to Disclose
 
Samuel A. Gold
No Relationships to Disclose
 
Kareem N. Rayn
No Relationships to Disclose
 
Sherif Mehralivand
No Relationships to Disclose
 
Bradford J. Wood
No Relationships to Disclose
 
Joanna H. Shih
No Relationships to Disclose
 
Baris Turkbey
Patents, Royalties, Other Intellectual Property - Royalties from US Government patents for MRI-US fusion biopsy, computer aided diagnosis software
Other Relationship - Navidea; Philips Healthcare
 
Peter A. Pinto
Patents, Royalties, Other Intellectual Property - NIH and Philips have a CRADA. NIH has intellectual property in the field, including among other patents and patent applications, Patent: “System, methods, and instrumentation for image guided prostate treatment” US Patent number: 8948845, with inventors/a